Filing Details
- Accession Number:
- 0001415889-21-004022
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-19 20:22:53
- Reporting Period:
- 2021-08-17
- Accepted Time:
- 2021-08-19 20:22:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1604821 | Natera Inc. | NTRA | Services-Medical Laboratories (8071) | 010894487 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1786240 | E Rowan Chapman | C/O Natera, Inc. 13011 Mccallen Pass Building A Suite 100 Austin TX 78753 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-08-17 | 5,500 | $32.15 | 10,356 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-08-17 | 5,500 | $100.09 | 4,856 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2021-08-17 | 5,500 | $0.00 | 5,500 | $32.15 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
16,500 | 2029-09-26 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2021. The Reporting Person is subject to a Lock-up Letter Agreement that expires on September 19, 2021. The sale of shares is a permissible exemption under the terms of the Lock-Up Letter Agreement.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.00 to $100.69 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- These reported shares are subject to restrictions in the Lock-Up Letter Agreement.
- The option shares vest over three years. A third of the option shares vested and became exercisable on August 15, 2020 and the remaining shares vest in 2 equal annual installments thereafter.